Wikipedia:Articles for deletion/Samarth Kulkarni


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was delete‎__EXPECTED_UNCONNECTED_PAGE__. The consensus here, relative to Wikipedia's guidelines and policies for deletion, is for deletion at this time. North America1000 14:10, 19 April 2024 (UTC)

Samarth Kulkarni

 * – ( View AfD View log | edits since nomination)

Non-notable CEO of a notable company. All of the sources cited are about the company, apart from this paywalled article in Stat about him winning a "best biopharma CEO" award reader poll. He has appeared on television news to discuss the company and biotech more generally, but those are primary sources, and I couldn't find solid, significant coverage of him in reliable secondary sources to show that he's notable independent from the company. Wikishovel (talk) 18:09, 28 March 2024 (UTC)
 * Note: This discussion has been included in the deletion sorting lists for the following topics: People, Businesspeople, Health and fitness, Biology, Technology,  and India. Wikishovel (talk) 18:09, 28 March 2024 (UTC)


 * Hi there Wikishovel,
 * I sent a note on my Talk page but perhaps it's more relevant here. My vote is to keep Kulkarni, and I disagree that he's a non-notable CEO due to the sheer amount of media mentions he has--paywalled and non-paywalled, in affiliation with his tenure at CRISPR. I think he warrants a Wikipedia page alongside other biopharma CEOs of far less newsworthy companies, particularly since he's heading, as you mentioned, a notable company. Would it help if I added/provided different or additional secondary sources? I can have a look around and see what else is available on record. Nathan Evo (talk) 18:48, 28 March 2024 (UTC)
 * Hi, yes please: if you can find reliable sources with substantial coverage of him, rather than about the company, then please do add them. Wikishovel (talk) 18:56, 28 March 2024 (UTC)

Relisting comment: The article appears to have been expanded since the last delete !vote was posted, although based on arguments made here the balance still favors deletion. Please add new comments below this notice. Thanks, signed,Rosguill talk 02:29, 5 April 2024 (UTC) Please add new comments below this notice. Thanks, The Herald (Benison) (talk) 04:37, 12 April 2024 (UTC)
 * Delete: Enough coverage about the company found, nothing for this person. This is all I can find in a RS that isn't a PR item; he is quoted in a brief paragraph of a few lines in an article about a conference. Nothing for GNG.  Oaktree b (talk) 18:52, 28 March 2024 (UTC)
 * redirect to CRISPR Therapeutics. - Altenmann >talk 19:40, 28 March 2024 (UTC)
 * Delete: no in-depth coverage. failed WP:N. Youknowwhoistheman (talk) 21:17, 28 March 2024 (UTC)
 * Note: This discussion has been included in the list of Karnataka-related deletion discussions.  Spiderone (Talk to Spider) 00:35, 29 March 2024 (UTC)
 * Keep: Added two additional sources underscoring his notability, principally as "one of the top 25 biotech CEOs of 2020" and "11 Asian-American Executives Shaping the Future of Biopharma." — Preceding unsigned comment added by Nathan Evo (talk • contribs) 19:38, 29 March 2024 (UTC)  — Note to closing admin: Nathan Evo (talk • contribs)  is the creator of the page that is the subject of this xfd.
 * Keep: He has more coverage than many Wikipedia execs and certainly enough news mentions to belong here, particularly given that he's in the top slot of biotech CEOs. passed WP:N. Georgieam 14:38 31 March 2024 (UTC) — Georgieam (talk&#32;• contribs) has made few or no other edits outside this topic.
 * Keep: Enough coverage in media to be notable.--Afus199620 (talk) 00:51, 1 April 2024 (UTC)
 *  Relisted to generate a more thorough discussion and clearer consensus.
 *  Relisted to generate a more thorough discussion and clearer consensus.
 * Keep: He's notable as a biotech leader and has more than enough media coverage.--Homerseditor, 11:39, 12 April 2024 (UTC)


 * Comment in response to the recent posts endorsing the WP:REFBOMBing, here's a source analysis:


 * Delete. WP:NOTCV and WP:NOTWHOSWHO, routine coverage and interviews are insufficent to write an article from. I don't think the content should be kept in article history either, though I suppose if it is I wouldn't be too broken up about it. Alpha3031 (t • c) 10:28, 19 April 2024 (UTC)


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.